Patient-initiated appointments compared with standard outpatient care for rheumatoid arthritis: a randomised controlled trial - PubMed (original) (raw)

Patient-initiated appointments compared with standard outpatient care for rheumatoid arthritis: a randomised controlled trial

Cecilia Fredriksson et al. RMD Open. 2016.

Abstract

Objectives: To test the hypothesis that implementing a patient-initiated system of care could improve clinical outcome in rheumatoid arthritis (RA) using disease activity guided management.

Methods: An 18-month controlled blinded end point two-centre study with 131 patients with RA randomised to intervention (n=64) or control (n=67). The intervention group participants were guaranteed appointments to a rheumatologist within 10 working days if they subjectively experienced a flare in disease activity. The control group participants were booked in advance according to guidelines. Independent assessments were performed in the two groups at 0, 3, 6, 12 and 18 months. Outcome measures included: Disease Activity Score 28 (DAS28), a Visual Analogue Scale (satisfaction with care, confidence in care), number of appointments with a rheumatologist.

Results: DAS28 decreased. Median satisfaction and confidence in care were >90 mm on Visual Analog Scale. Median number of appointments was 3. There were no significant differences between the groups among these outcomes. Visits in the intervention group more often resulted in change of treatment than in the control group (p<0.001).

Conclusions: Patient-initiated care was neither better nor inferior to traditional care in terms of outcomes analysed. Patient-initiated appointments can safely be used in everyday outpatient care of RA to empower the patient, if disease activity guided management is applied. Further research should investigate if this intervention can target a subgroup of patients and hence also result in released resources.

Keywords: Early Rheumatoid Arthritis; Health services research; Outcomes research; Rheumatoid Arthritis.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Flowchart of participants’ progress through the trial.

Figure 2

Figure 2

Percentage of patients in the disease activity index categories at 0 and 18 months.

Similar articles

Cited by

References

    1. Pollard L, Choy EH, Scott DL. The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol 2005;23(Suppl 39):S43–52. - PubMed
    1. Emery P, Breedveld FC, Hall S et al. . Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 2008;372:375–82. 10.1016/S0140-6736(08)61000-4 - DOI - PubMed
    1. Fransen J, Moens HB, Speyer I et al. . Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis 2005;64:1294–8. 10.1136/ard.2004.030924 - DOI - PMC - PubMed
    1. Bakker MF, Jacobs JW, Verstappen SM et al. . Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility. Ann Rheum Dis 2007;66(Suppl 3):iii56–60. 10.1136/ard.2007.078360 - DOI - PMC - PubMed
    1. Verstappen SM, Jacobs JW, van der Veen MJ et al. . Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443–9. 10.1136/ard.2007.071092 - DOI - PMC - PubMed

LinkOut - more resources